Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (5y) (2015 - 2023)
Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Rigel Pharmaceuticals | 701.96 Mn | 555.27 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -15.92% |
| Sep 30, 2023 | -38.26% |
| Jun 30, 2023 | -14.89% |
| Mar 31, 2023 | -20.09% |
| Dec 31, 2022 | 42.62% |
| Sep 30, 2022 | -69.78% |
| Jun 30, 2022 | -19.23% |
| Mar 31, 2022 | 54.45% |
| Dec 31, 2021 | -20.43% |
| Sep 30, 2021 | 17.62% |
| Jun 30, 2021 | 16.56% |
| Mar 31, 2021 | -15.08% |
| Dec 31, 2020 | 53.39% |
| Sep 30, 2020 | -19.04% |
| Jun 30, 2020 | -74.65% |
| Mar 31, 2020 | 88.31% |
| Dec 31, 2019 | 49.53% |
| Sep 30, 2019 | 14.76% |
| Jun 30, 2019 | -17.22% |
| Mar 31, 2019 | -15.25% |